Ulrike Bacher Selected Research

Lymphoma (Lymphomas)

12/2023	Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma.
9/2022	Combining BeEAM with Brentuximab Vedotin for High-Dose Therapy in CD30 Positive Lymphomas before Autologous Transplantation-A Phase I Study.
2/2021	Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation.
10/2020	Reduced survival after autologous stem cell transplantation in myeloma and lymphoma patients with low vitamin D serum levels.
12/2019	High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients.
11/2019	Rationale for a Combination Therapy Consisting of MCL1- and MEK-Inhibitors in Acute Myeloid Leukemia.
10/2016	Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
10/2015	Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrike Bacher Research Topics

Disease

43	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 04/2005
30	Neoplasms (Cancer) 11/2023 - 01/2009
18	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2022 - 01/2010
15	Multiple Myeloma 12/2023 - 07/2009
14	Leukemia 04/2024 - 05/2007
13	Residual Neoplasm 02/2023 - 01/2008
12	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 04/2005
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2024 - 11/2012
9	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 08/2008
8	Lymphoma (Lymphomas) 12/2023 - 10/2015
7	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 01/2010
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 04/2005
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 05/2009
6	Primary Myelofibrosis (Myelosclerosis) 12/2020 - 02/2009
5	Pathologic Complete Response 05/2024 - 01/2013
5	COVID-19 11/2023 - 06/2021
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2023 - 12/2013
4	Cytokine Release Syndrome 01/2023 - 01/2020
4	Infections 12/2022 - 01/2015
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 10/2009
3	cell-associated neurotoxicity 03/2023 - 01/2023
3	Hodgkin Disease (Hodgkin's Disease) 09/2022 - 01/2011
3	Fever (Fevers) 02/2021 - 01/2017
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 05/2011
3	Bronchiolitis Obliterans Syndrome 10/2015 - 08/2008
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 01/2011
2	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2022 - 01/2021
2	Disease Progression 01/2022 - 05/2011
2	Blast Crisis (Blast Phase) 10/2020 - 03/2010
2	Thrombocytosis (Thrombocythemia) 04/2019 - 05/2013
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 12/2015
2	Refractory Anemia 05/2013 - 06/2007
2	Acute Promyelocytic Leukemia 12/2011 - 05/2007
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2011 - 05/2010
1	Hematologic Diseases (Blood Diseases) 01/2024
1	Colitis 04/2023
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 03/2023
1	COVID-19 breakthrough infections 11/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 09/2022

Drug/Important Bio-Agent (IBA)

13	Chimeric Antigen ReceptorsIBA 05/2024 - 01/2020
6	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2009
5	Melphalan (Alkeran)FDA LinkGeneric 05/2023 - 01/2017
5	Busulfan (Busulfex)FDA Link 02/2023 - 08/2008
4	Messenger RNA (mRNA)IBA 11/2023 - 12/2013
4	Biomarkers (Surrogate Marker)IBA 04/2019 - 06/2011
4	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 03/2010
3	Phosphotransferases (Kinase)IBA 03/2024 - 06/2010
3	Apoptosis Regulatory ProteinsIBA 03/2024 - 10/2022
3	Immunoglobulin G (IgG)IBA 11/2022 - 10/2015
3	fludarabineIBA 11/2021 - 01/2013
3	S63845IBA 07/2021 - 11/2019
3	Rituximab (Mabthera)FDA Link 01/2020 - 01/2010
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 08/2008
3	AntigensIBA 05/2013 - 01/2011
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2012 - 01/2008
2	mRNA VaccinesIBA 11/2023 - 07/2022
2	Monoclonal AntibodiesIBA 07/2023 - 05/2009
2	treosulfanIBA 05/2023 - 05/2009
2	Bendamustine Hydrochloride FDA Link 03/2023 - 12/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 02/2021
2	VaccinesIBA 11/2022 - 07/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 02/2022
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2021 - 11/2019
2	trametinibIBA 02/2021 - 11/2019
2	Core Binding Factors (Core-Binding Factor)IBA 01/2020 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 10/2012
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 06/2017
2	EpitopesIBA 01/2016 - 05/2011
1	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 08/2023
1	Molecular Chaperones (Chaperone, Molecular)IBA 08/2023
1	Azacitidine (5 Azacytidine)FDA Link 07/2023
1	EnzymesIBA 04/2023
1	Dacarbazine (DIC)FDA LinkGeneric 04/2023
1	idecabtagene vicleucelIBA 04/2023
1	Bortezomib (Velcade)FDA Link 03/2023
1	Cell-Free Nucleic AcidsIBA 03/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023
1	ixazomibIBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	blinatumomabIBA 12/2022
1	AntibodiesIBA 11/2022
1	venetoclaxIBA 10/2022
1	Brentuximab VedotinIBA 09/2022
1	COVID-19 VaccinesIBA 07/2022
1	ElementsIBA 07/2022
1	Bispecific AntibodiesIBA 01/2022

Therapy/Procedure

49	Stem Cell Transplantation 05/2023 - 08/2008
33	Therapeutics 05/2024 - 05/2007
24	Cell Transplantation 11/2023 - 01/2012
18	Drug Therapy (Chemotherapy) 12/2023 - 12/2011
16	Hematopoietic Stem Cell Transplantation 04/2024 - 12/2010
16	Transplantation 01/2023 - 09/2010
8	Homologous Transplantation 11/2021 - 09/2010
5	Induction Chemotherapy 04/2024 - 07/2006
5	Hematopoietic Stem Cell Mobilization 01/2023 - 01/2018
4	Autologous Transplantation 09/2022 - 01/2018
2	Immunotherapy 11/2023 - 07/2009
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2023
1	Donor Selection 03/2022